SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gould, L.
Right arrow Articles by Abdou, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gould, L.
Right arrow Articles by Abdou, O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Hazardous Substances DB
*PRAZOSIN HYDROCHLORIDE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Noninvasive Assessment of Left Ventricular Wall Stress in Chronic Congestive Heart Failure Patients

Lawrence Gould

Department of Medicine, The Methodist Hospital, Brooklyn, NY

C. Gopalaswamy

Department of Medicine, The Methodist Hospital, Brooklyn, NY

F. Chandy

Department of Medicine, The Methodist Hospital, Brooklyn, NY

O. Abdou

Department of Medicine, The Methodist Hospital, Brooklyn, NY

In 1969, our group first reported that the intravenous administration of phentolamine can improve cardiac performance in patients with heart failure. 1 Positive inotropism and a reduction in afterload were shown to be the mechanisms that led to cardiac improvement. Since that time the literature is replete with articles attesting to the benefits of vasodilator drugs in the treat ment of acute and chronic heart failure.

A reduction in impedance or afterload should produce beneficial hemodynamic effects in patients with left ventricular volume overload due to aortic insufficiency or mitral insufficiency. This has been verified using an intravenous infusion of nitroprusside, 2,3 phentolamine4 and hydralazine.5,6

The effects of vasodilators on left ventricular wall stress can now be evaluated noninvasively. Recently Wilson and his group7 documented that nitroglycerin can effectively reduce the peak and end systolic wall stress in patients with aortic regurgitation. These authors concluded that the beneficial action of nitroglycerin on muscle mechanics might retard left ventricular enlargement and hypertrophy and consequently delay the onset of myocardial dysfunction.

Prazosin is an oral drug with sustained vasodilator properties similar to nitroprusside which is widely used in the treatment of heart failure. This drug is a quinazoline derivative structurally unrelated to other vasodilator drugs pre sently available. It acts principally by blockade of vascular alpha-adrenergic receptors. It selectively blocks the postsynoptic or alpha 1 receptor while having little affinity for the pre-synoptic or alpha 2 receptor.

Angiology, Vol. 34, No. 2, 111-118 (1983)
DOI: 10.1177/000331978303400205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement